RPRX logo

Royalty Pharma (RPRX) Operating Expenses

Annual Operating Expenses

$862.40 M
-$451.92 M-34.38%

December 31, 2023


Summary


Performance

RPRX Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRPRXexpensesmetrics:

Quarterly Operating Expenses

-$170.38 M
-$438.02 M-163.66%

September 30, 2024


Summary


Performance

RPRX Quarterly Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRPRXexpensesmetrics:

Operating Expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

RPRX Operating Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-34.4%-126.5%
3 y3 years+86.7%-126.5%
5 y5 years+100.3%-149.8%

RPRX Operating Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-34.4%+0.4%-126.5%at low
5 y5-year-34.4%+206.6%-126.5%+80.5%
alltimeall time-34.4%+206.6%-126.5%+80.5%

Royalty Pharma Operating Expenses History

DateAnnualQuarterly
Sep 2024
-
-$170.38 M(-163.7%)
Jun 2024
-
$267.64 M(-58.3%)
Mar 2024
-
$641.75 M(-3913.6%)
Dec 2023
$862.40 M(-34.4%)
-$16.83 M(-104.4%)
Sep 2023
-
$384.87 M(+33.0%)
Jun 2023
-
$289.36 M(+41.2%)
Mar 2023
-
$205.00 M(-52.6%)
Dec 2022
$1.31 B(+53.1%)
$432.58 M(+13.5%)
Sep 2022
-
$381.25 M(+141.1%)
Jun 2022
-
$158.16 M(-53.8%)
Mar 2022
-
$342.33 M(-18.9%)
Dec 2021
$858.75 M
$422.28 M(+49.4%)
DateAnnualQuarterly
Sep 2021
-
$282.72 M(-248.8%)
Jun 2021
-
-$189.99 M(-155.3%)
Mar 2021
-
$343.73 M(+78.1%)
Dec 2020
$461.90 M(-157.1%)
$193.03 M(+593.6%)
Sep 2020
-
$27.83 M(-72.6%)
Jun 2020
-
$101.59 M(-27.2%)
Mar 2020
-
$139.45 M(-115.9%)
Dec 2019
-$808.92 M(-287.9%)
-$874.43 M(+1181.8%)
Sep 2019
-
-$68.22 M(-152.6%)
Jun 2019
-
$129.75 M(+3157.6%)
Mar 2019
-
$3.98 M
Dec 2018
$430.45 M(-34.6%)
-
Dec 2017
$658.24 M
-

FAQ

  • What is Royalty Pharma annual total operating expenses?
  • What is the all time high annual operating expenses for Royalty Pharma?
  • What is Royalty Pharma annual operating expenses year-on-year change?
  • What is Royalty Pharma quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Royalty Pharma?
  • What is Royalty Pharma quarterly operating expenses year-on-year change?

What is Royalty Pharma annual total operating expenses?

The current annual operating expenses of RPRX is $862.40 M

What is the all time high annual operating expenses for Royalty Pharma?

Royalty Pharma all-time high annual total operating expenses is $1.31 B

What is Royalty Pharma annual operating expenses year-on-year change?

Over the past year, RPRX annual total operating expenses has changed by -$451.92 M (-34.38%)

What is Royalty Pharma quarterly total operating expenses?

The current quarterly operating expenses of RPRX is -$170.38 M

What is the all time high quarterly operating expenses for Royalty Pharma?

Royalty Pharma all-time high quarterly total operating expenses is $641.75 M

What is Royalty Pharma quarterly operating expenses year-on-year change?

Over the past year, RPRX quarterly total operating expenses has changed by -$812.14 M (-126.55%)